Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
Showing 841 - 860 results of 14,257 for search '(( significant ((greatest decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', query time: 0.55s Refine Results
  1. 841
    Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).

    Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 842
    Comparing detector performance against increasing signal to noise ratios.

    Comparing detector performance against increasing signal to noise ratios. by Bernd Porr (32394)

    Published 2024
    Save to List
    Saved in:
  3. 843
    Upwelling index series.

    Upwelling index series. by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 844
    δ<sup>15</sup>N in <i>Fucus spiralis</i> vs. <i>F. vesiculosus.</i>

    δ<sup>15</sup>N in <i>Fucus spiralis</i> vs. <i>F. vesiculosus.</i> by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 845
    A) RT-qPCR analysis of <i>Yap</i>, <i>Taz</i>, and <i>Tead2</i> shows a significant decrease in transcript levels over postnatal stages from P0 to P28.

    A) RT-qPCR analysis of <i>Yap</i>, <i>Taz</i>, and <i>Tead2</i> shows a significant decrease in transcript levels over postnatal stages from P0 to P28. by Heather L. Dingwall (14573796)

    Published 2025
    Save to List
    Saved in:
  6. 846
    δ<sup>15</sup>N in <i>Fucus spp. vs. Bifurcaria bifurcata.</i>

    δ<sup>15</sup>N in <i>Fucus spp. vs. Bifurcaria bifurcata.</i> by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 847
    Stable isotopes in algae and mussels.

    Stable isotopes in algae and mussels. by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 848
    Seasonality of δ<sup>15</sup>N in <i>Mytilus galloprovincialis.</i>

    Seasonality of δ<sup>15</sup>N in <i>Mytilus galloprovincialis.</i> by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 849
    Seasonality of δ<sup>15</sup>N in <i>Fucus spiralis.</i>

    Seasonality of δ<sup>15</sup>N in <i>Fucus spiralis.</i> by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 850
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 851
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 852
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 853
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 854
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 855
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 856
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 857
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 858
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 859
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 860
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: